Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYMS | P04818 | 8/20 | 0.42 |
| ▸ | DHFR | P00374 | 1/20 | 0.42 |
| ▸ | PTPN11 | Q06124 | 4/20 | 0.39 |
| ▸ | XDH | P47989 | 2/20 | 0.36 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.35 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.35 |
| ▸ | MASP2 | O00187 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7512558 | 0.78 | RXFP1 (0.50) | TYMSDHFRXDH | |
| SCHEMBL7515297 | 0.78 | ITGB2 (0.50) | TYMSDHFRPTPN11XDHMAPK14 | |
| SCHEMBL7519197 | 0.76 | MAPK11 (0.41) | TYMSPTPN11MAPK14 | |
| SCHEMBL7515639 | 0.76 | TYMS (0.51) | TYMSDHFRXDHAOC3MASP2 | |
| SCHEMBL7518203 | 0.73 | TYMS (0.37) | TYMSXDHMAPK14 | |
| SCHEMBL6049582 | 0.72 | NUDT1 (0.50) | TYMSPTPN11XDH | |
| SCHEMBL7515343 | 0.72 | TYMS (0.42) | TYMSDHFRXDH | |
| SCHEMBL11543373 | 0.72 | — | — | |
| SCHEMBL23339220 | 0.71 | NOS1 (0.40) | TYMSXDHAOC3MASP2 | |
| SCHEMBL7518650 | 0.69 | TYMS (0.43) | TYMSDHFRAOC3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1165522-A1 | NEUROTROPHIC THIO SUBSTITUTED PYRIMIDINES | Krenitsky Pharmaceuticals, Inc. (US) | 2002-01-02 | — | — | EP | disclosed |
| WO-2000059893-A1 | NEUROTROPHIC THIO SUBSTITUTED PYRIMIDINES | KRENITSKY PHARMACEUTICALS INC. (US) | 2000-10-12 | — | — | WO | disclosed |